VERTEX PHARMACEUTICALS INC / MA Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2018 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Operating Lease, Liability, Noncurrent for the quarter ending September 30, 2024 was $1.59B, a 348% increase year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.59B +$1.23B +348% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $587M +$223M +61.4% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $360M -$11.8M -3.18% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $349M -$30.9M -8.14% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $354M -$27.9M -7.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $364M -$1.5M -0.41% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $372M -$5.4M -1.43% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $380M +$2.1M +0.56% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $382M +$18.8M +5.16% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $365M -$3.92M -1.06% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $377M +$8.53M +2.32% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $377M +$26.9M +7.68% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $364M Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $369M Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $368M Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $351M +$266M +316% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $84.3M +$19.4M +30% Dec 31, 2019 10-K 2021-02-11
Q3 2019 $63M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $60.4M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $63.5M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $64.8M Jan 1, 2019 10-Q 2019-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.